TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 2.3B
Gross Profit 567.0M 24.76%
Operating Income 318.0M 13.89%
Net Income 183.0M 7.99%
EPS (Diluted) $1.57

Balance Sheet Metrics

Total Assets 15.0B
Total Liabilities 9.0B
Shareholders Equity 5.9B
Debt to Equity 1.52

Cash Flow Metrics

Operating Cash Flow -167.0M
Free Cash Flow -314.0M

Revenue & Profitability Trend

Eastman Chemical Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i9.4B9.2B10.6B10.5B8.5B
Cost of Goods Sold i7.1B7.1B8.4B8.0B6.5B
Gross Profit i2.3B2.1B2.1B2.5B2.0B
Gross Margin % i24.4%22.4%20.2%23.9%23.3%
Operating Expenses
Research & Development i250.0M239.0M264.0M254.0M226.0M
Selling, General & Administrative i664.0M768.0M625.0M383.0M654.0M
Other Operating Expenses i-----
Total Operating Expenses i914.0M1.0B889.0M637.0M880.0M
Operating Income i1.4B1.1B1.2B1.9B1.1B
Operating Margin % i14.7%11.4%11.8%17.8%12.9%
Non-Operating Items
Interest Income i16.0M10.0M6.0M3.0M4.0M
Interest Expense i216.0M225.0M188.0M198.0M210.0M
Other Non-Operating Income-98.0M248.0M-89.0M-583.0M-355.0M
Pre-tax Income i1.1B1.1B977.0M1.1B530.0M
Income Tax i170.0M191.0M181.0M215.0M41.0M
Effective Tax Rate % i15.8%17.6%18.5%19.9%7.7%
Net Income i908.0M896.0M796.0M867.0M489.0M
Net Margin % i9.7%9.7%7.5%8.3%5.8%
Key Metrics
EBITDA i1.9B1.5B1.7B2.4B1.5B
EPS (Basic) i$7.75$7.54$6.42$6.35$3.53
EPS (Diluted) i$7.67$7.49$6.35$6.25$3.50
Basic Shares Outstanding i116700000118600000123500000134900000135500000
Diluted Shares Outstanding i116700000118600000123500000134900000135500000

Income Statement Trend

Eastman Chemical Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i837.0M548.0M493.0M459.0M564.0M
Short-term Investments i-----
Accounts Receivable i791.0M826.0M957.0M1.1B1.0B
Inventory i2.0B1.7B1.9B1.5B1.4B
Other Current Assets104.0M96.0M114.0M96.0M83.0M
Total Current Assets i4.1B3.5B3.8B4.6B3.5B
Non-Current Assets
Property, Plant & Equipment i00000
Goodwill i8.3B8.4B8.5B8.6B10.7B
Intangible Assets i1.0B1.1B1.2B1.4B1.8B
Long-term Investments-----
Other Non-Current Assets833.0M820.0M855.0M874.0M736.0M
Total Non-Current Assets i11.1B11.2B10.9B10.9B12.5B
Total Assets i15.2B14.6B14.7B15.5B16.1B
Liabilities
Current Liabilities
Accounts Payable i1.3B1.2B1.3B1.2B799.0M
Short-term Debt i450.0M541.0M1.1B747.0M349.0M
Current Portion of Long-term Debt-----
Other Current Liabilities428.0M270.0M288.0M376.0M252.0M
Total Current Liabilities i2.7B2.6B3.3B3.0B2.0B
Non-Current Liabilities
Long-term Debt i4.6B4.3B4.0B4.4B5.3B
Deferred Tax Liabilities i533.0M601.0M671.0M810.0M848.0M
Other Non-Current Liabilities923.0M954.0M856.0M727.0M677.0M
Total Non-Current Liabilities i6.7B6.5B6.2B6.8B7.9B
Total Liabilities i9.4B9.1B9.4B9.7B10.0B
Equity
Common Stock i2.0M2.0M2.0M2.0M2.0M
Retained Earnings i10.0B9.5B9.0B8.6B8.1B
Treasury Stock i6.4B6.1B5.9B4.9B4.0B
Other Equity-----
Total Shareholders Equity i5.9B5.5B5.2B5.8B6.1B
Key Metrics
Total Debt i5.0B4.8B5.2B5.2B5.6B
Working Capital i1.4B905.0M527.0M1.7B1.5B

Balance Sheet Composition

Eastman Chemical Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i908.0M896.0M796.0M867.0M489.0M
Depreciation & Amortization i509.0M498.0M477.0M538.0M574.0M
Stock-Based Compensation i-----
Working Capital Changes i-77.0M291.0M13.0M-27.0M165.0M
Operating Cash Flow i1.3B1.7B898.0M1.3B1.1B
Investing Activities
Capital Expenditures i-599.0M-828.0M-611.0M-555.0M-383.0M
Acquisitions i38.0M379.0M997.0M553.0M-1.0M
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-534.0M-427.0M405.0M-6.0M-381.0M
Financing Activities
Share Repurchases i-300.0M-150.0M-1.0B-1.0B-60.0M
Dividends Paid i-379.0M-376.0M-381.0M-375.0M-358.0M
Debt Issuance i1.2B796.0M500.0M0249.0M
Debt Repayment i-1.0B-808.0M-750.0M-300.0M-435.0M
Financing Cash Flow i-454.0M-888.0M-1.3B-1.7B-704.0M
Free Cash Flow i688.0M541.0M351.0M1.0B1.1B
Net Change in Cash i348.0M344.0M-18.0M-379.0M-17.0M

Cash Flow Trend

Eastman Chemical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 9.29
Forward P/E 7.59
Price to Book 1.30
Price to Sales 0.82
PEG Ratio -0.25

Profitability Ratios

Profit Margin 8.96%
Operating Margin 12.42%
Return on Equity 14.39%
Return on Assets 5.54%

Financial Health

Current Ratio 1.68
Debt to Equity 90.60
Beta 1.23

Per Share Data

EPS (TTM) $7.11
Book Value per Share $50.84
Revenue per Share $80.36

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
emn7.6B9.291.3014.39%8.96%90.60
Linde plc 222.6B34.375.8617.01%20.02%60.56
Sherwin-Williams 91.5B36.3920.7062.43%11.03%308.57
Albemarle 9.9B33.521.26-9.99%-22.39%35.76
NewMarket 7.4B15.624.6033.74%17.28%56.98
Axalta Coating 6.7B15.232.9721.70%8.58%147.77

Financial data is updated regularly. All figures are in the company's reporting currency.